-
Catholic University - KIST Develop Coronavirus Vaccine Platform Applicable to COVID-19Author : 관리자Date : 2020.04.14Hit : 612
-
Protein-based vaccine developed by using RNA; efficacy confirmed against MERS-CoV
Raises hope for early development of a safe vaccine against the same coronavirus COVID-19
The Department of Biotechnology research team led by Professor Nam Jae-hwan saw a possibility of development of a vaccine against coronaviruses such as COVID-19 (SARS-CoV2), through joint research with KIST Neuro-medicine research group. The research team announced that it developed a vaccine platform for Middle East Respiratory Syndrome Coronavirus (MERS-CoV), one of the coronaviruses, using an RNA-based immune booster and stabilizer.
-
Attachment File